×
Join our live online event
How top hedge funds use news to make money
form the stock market & how ordinary people are
copying their strategies
Register now!
form the stock market & how ordinary people are
copying their strategies
No thanks
HUMA – humacyte, inc. (US:NASDAQ)
DELAYED
$
| Volume Shares | |
| 1 Day Range | |
| Volume Ratio | |
| 52 Week High | |
| 52 Week Low |
| VWAP | |
| Today’s Volatility | |
| 20 Days Volatility | |
| Open | |
| Prior Close |
1D
5D
1M
3M
YTD
1Y
3Y
1 Day
HUMA
SPY
QQQ
Swipe to see more
Main News & Impact Reports
Date
Time
Symbol
Headline
Impact
12/1
07:20 am
huma
Humacyte (NASDAQ:HUMA) had its "buy" rating reaffirmed by analysts at UBS Group AG.
Medium
Report
Humacyte (NASDAQ:HUMA) had its "buy" rating reaffirmed by analysts at UBS Group AG.
12/1
07:20 am
huma
Humacyte (NASDAQ:HUMA) had its "buy" rating reaffirmed by analysts at HC Wainwright.
Medium
Report
Humacyte (NASDAQ:HUMA) had its "buy" rating reaffirmed by analysts at HC Wainwright.
11/27
06:40 pm
huma
Humacyte (HUMA) Q3 2025 Earnings Call Transcript [Yahoo! Finance]
Low
Report
Humacyte (HUMA) Q3 2025 Earnings Call Transcript [Yahoo! Finance]
11/21
08:05 am
huma
Humacyte (NASDAQ:HUMA) had its "buy" rating reaffirmed by analysts at BTIG Research. They now have a $6.00 price target on the stock.
Medium
Report
Humacyte (NASDAQ:HUMA) had its "buy" rating reaffirmed by analysts at BTIG Research. They now have a $6.00 price target on the stock.
11/20
09:46 am
huma
Humacyte (NASDAQ:HUMA) had its "buy" rating reaffirmed by analysts at D. Boral Capital. They now have a $25.00 price target on the stock.
Medium
Report
Humacyte (NASDAQ:HUMA) had its "buy" rating reaffirmed by analysts at D. Boral Capital. They now have a $25.00 price target on the stock.
11/20
08:00 am
huma
Humacyte Announces Presentations at VEITHsymposium Highlighting Positive Acellular Tissue Engineered Vessel (ATEV™) Clinical Results
Medium
Report
Humacyte Announces Presentations at VEITHsymposium Highlighting Positive Acellular Tissue Engineered Vessel (ATEV™) Clinical Results
11/13
01:39 pm
huma
Humacyte (NASDAQ:HUMA) had its price target lowered by analysts at Benchmark Co. from $14.00 to $11.00. They now have a "buy" rating on the stock.
Low
Report
Humacyte (NASDAQ:HUMA) had its price target lowered by analysts at Benchmark Co. from $14.00 to $11.00. They now have a "buy" rating on the stock.
11/13
08:38 am
huma
Humacyte Announces Six Presentations Scheduled for the Upcoming 52nd Annual Symposium on Vascular and Endovascular Issues, Techniques and Horizons (VEITHsymposium) [Yahoo! Finance]
Medium
Report
Humacyte Announces Six Presentations Scheduled for the Upcoming 52nd Annual Symposium on Vascular and Endovascular Issues, Techniques and Horizons (VEITHsymposium) [Yahoo! Finance]
Date
Time
Symbol
Company Name
Action
%Chg
Date
Time
Action
From
To
Firm
Impact
%Chg
Date
Time
Symbol
Headline
Impact
11/26
05:01 pm
huma
Form 8-K Humacyte, Inc. For: Nov 21
Low
Report
Form 8-K Humacyte, Inc. For: Nov 21
11/17
05:52 pm
huma
Form 4 Humacyte, Inc. For: Nov 16 Filed by: Sander Dale A.
Medium
Report
Form 4 Humacyte, Inc. For: Nov 16 Filed by: Sander Dale A.
11/17
05:51 pm
huma
Form 4 Humacyte, Inc. For: Nov 16 Filed by: Parikh Shamik J
Medium
Report
Form 4 Humacyte, Inc. For: Nov 16 Filed by: Parikh Shamik J
11/17
05:50 pm
huma
Form 4 Humacyte, Inc. For: Nov 16 Filed by: Dougan Brady W
Medium
Report
Form 4 Humacyte, Inc. For: Nov 16 Filed by: Dougan Brady W
11/17
05:48 pm
huma
Form 4 Humacyte, Inc. For: Nov 16 Filed by: Niklason Laura E
Medium
Report
Form 4 Humacyte, Inc. For: Nov 16 Filed by: Niklason Laura E
11/12
04:47 pm
huma
Form 10-Q Humacyte, Inc. For: Sep 30
Medium
Report
Form 10-Q Humacyte, Inc. For: Sep 30
11/12
07:06 am
huma
Form 8-K Humacyte, Inc. For: Nov 12
Medium
Report
Form 8-K Humacyte, Inc. For: Nov 12
10/16
05:25 pm
huma
Form SCHEDULE 13D/A Humacyte, Inc. Filed by: Fresenius Medical Care AG
Low
Report
Form SCHEDULE 13D/A Humacyte, Inc. Filed by: Fresenius Medical Care AG
Stock Stats
| News Stats | |
|---|---|
| All News | |
| News Wires | |
| Media Monitoring | |
| SEC Edgar Filings | |
| Upgrades | |
| Downgrades | |
| Initiated | |
| Reiterated | |
| Last Earnings | |
| Last Earnings EPS | |
| Next Earnings | |
| Order Stats |
|---|
| Sub-Penny |
|
|
| Odd lot |
|
|
| Avg. bid-ask spread |
|
|
| Avg. bid-ask size |
|
|
| Shares at ask/bid |
|
|
| Off exchange |
|
|
Main News & Impact Reports
TOP News Gainers
TOP News Decliners
Don’t Miss Out On The Next BIG Stock Move
Never get left behind with our daily ‘Shakers & Movers’ newsletter. Discover the biggest gainer or loser in the stock market, and learn exactly WHY it moved. To find out which one caught Wall Street by surprise TODAY, sign up to our newsletter below: